Administration of TRAIL protein, TRAIL gene therapy, or TRAIL bone marrow transplantation attenuated atherosclerosis development, reduced macrophage content in the vessel wall, and reduced inflammation in diabetic Apoe−/− or Trail−/−Apoe−/− mice [23,70]. Here, TNFSF10 is linked to atherosclerosis.